Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus.

Trial Profile

Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 10 May 2017

At a glance

  • Drugs Simvastatin (Primary)
  • Indications Systemic lupus erythematosus
  • Focus Pharmacodynamics
  • Sponsors Merck & Co
  • Most Recent Events

    • 15 Dec 2010 Actual patient number is 4 according to ClinicalTrials.gov.
    • 08 Jul 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 13 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top